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Variation in venom composition is a ubiquitous phenomenon in
snakes and occurs both interspecifically and intraspecifically.
Venom variation can have severe outcomes for snakebite victims
by rendering the specific antibodies found in antivenoms in-
effective against heterologous toxins found in different venoms.
The rapid evolutionary expansion of different toxin-encoding
gene families in different snake lineages is widely perceived as the
main cause of venom variation. However, this view is simplistic
and disregards the understudied influence that processes acting
on gene transcription and translation may have on the production
of the venom proteome. Here, we assess the venom composition
of six related viperid snakes and compare interspecific changes in
the number of toxin genes, their transcription in the venom gland,
and their translation into proteins secreted in venom. Our results
reveal that multiple levels of regulation are responsible for gen-
erating variation in venom composition between related snake
species. We demonstrate that differential levels of toxin transcrip-
tion, translation, and their posttranslational modification have
a substantial impact upon the resulting venom protein mixture.
Notably, these processes act to varying extents on different toxin
paralogs found in different snakes and are therefore likely to
be as important as ancestral gene duplication events for generat-
ing compositionally distinct venom proteomes. Our results sug-
gest that these processes may also contribute to altering the
toxicity of snake venoms, and we demonstrate how this variability
can undermine the treatment of a neglected tropical disease,
snakebite.
Venom systems are important adaptations that have evolvedindependently on many occasions in different animal line-
ages (1). Of all venomous animals, snakes are the most well-
known because of their medical importance: As many as 90,000
people die each year as the result of snakebite, with the majority of
those inhabiting rural poor regions of the tropics (2, 3). This
substantial mortality burden of snakebite victims is surprising be-
cause antivenom treatment (immunoglobulins from venom-im-
munized horses/sheep) can be highly effective at neutralizing the
toxic components present in snake venom (4, 5). However, the
efficacy of these therapies is largely restricted to the snake species
whose venom was used in manufacture. This limitation arises
because variation in venom composition is ubiquitous at every
level of snake taxonomy, including interspecifically and intra-
specifically and even ontogenetically (6–9). Importantly, the extent
of this variation is not simply reflected by taxonomic distance
(9–11) and, therefore, cannot be readily predicted. The conse-
quence of venom variation is that antivenoms raised against any
particular species of snake are often ineffective in treating
snakebite by different, even closely related, species (5, 12, 13).
Snake venoms are used for predation. They primarily consist of
proteins and peptides (commonly referred to as toxins) that exert
neurotoxic, hemotoxic, and/or cytotoxic pathologies in envenom-
ed prey and humans. Typically, toxins are encoded by relatively
few (approximately 5–10) multilocus gene families, with each
family capable of producing related isoforms generated by
gene duplication events occurring over evolutionary time (1, 14,
15). The birth and death model of gene evolution (16) is fre-
quently invoked as the mechanism giving rise to venom gene
paralogs, with evidence that natural selection acting on surface
exposed residues of the resulting gene duplicates facilitates
subfunctionalization/neofunctionalization of the encoded proteins
(15, 17–19). The result of these processes is a complex suite of
toxins that act synergistically to cause rapid prey death. Conse-
quently, it has been hypothesized that variation in venom com-
position is the result of adaptation in response to dietary selection
pressures (1, 9, 11, 20).
There is some evidence that genome-level effects, i.e., the
presence or absence of key toxin genes in the genome of ven-
omous snakes, can dictate major shifts in venom composition
(21). However, the assumption that the presence or absence
of toxin gene paralogs is responsible for causing all cases
of observed venom variation is overly simplistic. Few studies
have attempted to investigate the factors impacting upon the
transcription of toxins from genes housed in the genome of the
venomous animal to the proteins secreted in venom. Although
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some studies have detected concordance between the abundance
of both toxin gene transcripts and proteins in snake venom sys-
tems (22, 23), many others have demonstrated that the toxin
genes detected in venom glands do not correlate well with the
composition of secreted venom (7, 24), suggesting that some
level of regulatory control acts on protein translation. How-
ever, most studies typically focused on comparisons at the toxin
family level by using a single species, which could be mislead-
ing if mechanisms affecting translation act differentially on tox-
in paralogs and, therefore, result in different outcomes in
different species.
Here, we take an integrated multispecies approach, coupling
molecular, proteomic, and evolutionary methodologies, to rig-
orously investigate the mechanisms responsible for generating
venom variation in snakes. We demonstrate that there is dis-
cordance between the number of genomic loci encoding toxin
genes with the number and abundance of genes transcribed in
the venom gland and with the number and abundance of toxins
translated as functional proteins. We find that transcriptional
and translational control mechanisms are likely to play a critical
role in the generation of compositionally and functionally dis-
tinct venoms found among related snake species. Ultimately, we
demonstrate that the action of these postgenomic processes can
restrict the snake-species efficacy of therapeutic antivenoms.
Results and Discussion
To investigate the mechanisms governing venom variation we
selected a related group of medically important viperid snakes:
four species of saw-scaled vipers (Echis ocellatus, Echis coloratus,
Echis pyramidum leakeyi, and Echis carinatus sochureki) and two
related species from different genera, the puff adder (Bitis arietans)
and the Saharan horned viper (Cerastes cerastes) (Fig. 1). These
species were selected based on their medical importance in
Africa and our previous descriptions of interspecific variation in
venom composition, dietary preference, and prey lethality (12,
20, 25, 26). We used our previously constructed and assembled
venom gland transcriptomes for the four Echis species (26, 27)
and prepared venom gland trancriptomes for B. arietans and
C. cerastes by using identical protocols. We generated proteomes
from venom extracted from each of these species (28) and used
translations of the transcriptomic datasets to facilitate protein
identification (SI Appendix, Figs. S1–S6 and Tables S1–S6). We
next compiled gene and protein abundance profiles for the toxin
families identified in the venom proteomes of the majority of
the sampled species [snake venom metalloproteinases (SVMPs),
serine proteases (SPs), C-type lectins (CTLs), phospholipase A2s
(PLA2s), disintegrins (DISs), cysteine rich secretory proteins
(CRISPs), and L-amino acid oxidases (LAAOs)]. These profiles
were mapped to the species phylogeny to reveal considerable
interspecific variation in both gene and protein abundance over
evolutionary time (Fig. 1).
The high abundance of SVMPs in the venom proteomes
(>50% of all toxins) of the four Echis species correlates with our
previous reports that these toxins are transcribed at the highest
level in the venom glands (26). The SVMPs, alongside the SPs,
represent the majority of toxin genes transcribed in the venom
glands of B. arietans and C. cerastes, and these are also the most
abundant proteins secreted in their venoms. However, the
quantitative proteomic representation of CTLs in B. arietans and
PLA2s in C. cerastes was greater than that predicted by the gene
transcription data (Fig. 1A). This disparity in transcriptomic and
proteomic abundance is notably high in some species (e.g.,
B. arietans and E. p. leakeyi), yet largely absent from others (e.g.,
E. ocellatus and E. coloratus) (Fig. 1A and SI Appendix, Fig. S7).
Illustrating this comparison in scatter plots reveals a rea-
sonable correlation between the total transcription of toxin
gene paralogs encoded by each gene family and their cumu-
lative proteomic abundance (Fig. 1B). However, this correlation
disappears when analyzing each gene paralog for each toxin
family individually, demonstrating that a variety of highly tran-
scribed toxin genes exhibit little to no proteomic representation,
and vice versa (Fig. 1C). The starkest examples involve the
SVMPs: A highly transcribed SVMP (24.49% of all toxins) in the
venom gland of E. ocellatus has relatively low abundance in
venom (4.33%), which is a pattern repeated with a paralogous
SVMP found in C. cerastes (8.73% transcriptome; 0.46% pro-
teome). Contrastingly, other toxins encoded by the same gene
family show the opposite pattern: Individual SVMPs from E. p.
leakeyi and E. c. sochureki exhibit considerably greater proteomic
than transcriptomic abundance (14.83% and 9.83% proteome;
3.69% and 0.97% transcriptome, respectively). Notably, none of
these toxins found in the different species are homologous. Our
results here demonstrate that intratoxin family variation between
the transcriptome and proteome of snake species can greatly
Fig. 1. The complex relationship between snake venom composition at the
gene and protein level. (A) Comparisons of gene transcription (transcript) in
the venom gland and protein abundance (protein) in secreted venom of the
sampled species. Percentage change from transcript to protein is displayed
in bar charts for visual purposes (see SI Appendix, Fig. S7 for detail). Arrows
indicate significant increases or decreases in transcriptomic (transparent) and
proteomic (solid) toxin family abundance over evolutionary time (calculated
by paired two-tailed t test of toxin representation between taxa found
within and outside each node, P < 0.05). The phylogeny is taken from refs.
20, 29, and 30). (B) Comparisons of total venom gland transcriptome and
venom proteome abundance summarized for all gene paralogs encoded
by each toxin family for each species. (C) Comparisons of individual gene
paralog abundance for each toxin family for each species. Solid lines indi-
cate linear trendlines (R2 values: B, 0.83; C, 0.26) and, for visual purposes,
dotted lines indicate equal gene and protein abundance.
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affect the composition of toxins found in snake venom. Mecha-
nisms affecting protein translation therefore appear capable of
acting differentially on toxin paralogs within a single gene family,
rather than supressing or enhancing the translation of all toxin
genes encoded by the same gene family.
To better understand the evolutionary steps underpinning this
complex interaction between gene transcription and protein se-
cretion of snake venom, we reconstructed gene phylogenies for
each toxin family identified across the venom proteomes (SVMP,
SP, CTL, PLA2, CRISP, and LAAO), by coupling venom gland
transcriptome data to phylogenetic analyses. Because relevant
genome information was lacking, we reconciled the resulting
gene trees to the previously described species tree (20, 29, 30) to
reconstruct the timing of gene duplication events and to predict
the number of untranscribed (or pseudogenic) gene loci. Such
reconciliation approaches have successfully been used elsewhere,
including with venom toxins, to predict the number of genes
housed in a genome in the absence of genomic information (31–
33). To determine which loci are translated into venom proteins,
we mapped the proteomic representation and abundance of each
toxin to the reconciled trees (SI Appendix, Figs. S8–S14).
Comparing the number of genomic loci inferred by our
reconciliation analyses with the number of transcribed genes
Fig. 2. Heat map visualization of venom toxins demonstrating variable
patterns of transcription and translation for gene homologs and paralogs.
The heat map is colored for genes predicted by reconciliation analysis, those
transcribed in the venom gland transcriptome, and those translated as se-
creted proteins detected in venom. Green represents presence, and red rep-
resents absence. To the left of each heat map is the tree topology for: (i) the
major clades found in the multilocus gene families (SVMP, CTL, SP, and PLA2)
and (ii) the single locus gene families (CRISP and LAAO). Genes are ordered by
phylogenetic clades (SI Appendix, Figs. S8–S14) with the species that each
gene was recovered from indicated by different colors displayed in the key.
Fig. 3. Variation in gene loci, gene transcription, and gene translation in
the snake venom system. (A) Comparisons between species. Data are dis-
played as the total number of gene loci, genes transcribed, and genes
translated for all venom toxin families in each species. (B) Comparisons be-
tween toxin families. Data are displayed as the mean number of gene loci
per species (Left) and the mean percentage of those genes transcribed and
translated summarized for all species (Right). Error bars represent SEM. Also
see SI Appendix, Fig. S15. (C) Variation in the composition of toxins found in
the venom system of B. arietans. (1) Predicted toxin genes that are untran-
scribed. (2) Venom gland transcribed toxin genes. (3) Corresponding toxins
detected in the venom proteome. (4) Proteolysed protein products derived
from each protein. Toxins are represented by nodes and their percentage
abundance by node size (scale does not apply to part 1). Crosses indicate
transcribed genes not translated. The orange node represents a predicted
CRISP gene that was untranscribed.
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(identified in the venom gland transcriptomes) and with the
number of translated proteins (identified in the venom pro-
teomes) revealed a surprisingly high pattern of gene redundancy
(Figs. 2 and 3A). The percentage of genomic loci transcribed as
toxin genes in the venom gland ranges from 44.12 to 70.15%
across the six species, whereas the percentage of those genomic
loci being translated into secreted venom toxins ranges from
35.29 to 52.08% (Fig. 3A). Whereas these results highlight the
likely influence of many genes becoming pseudogenic, as pre-
dicted by the birth and death model of gene evolution (16), they
also strongly indicate that transcriptional and translational reg-
ulatory control mechanisms have a major influence on the pro-
duction of venom secretions. Venom gland microRNAs have
recently been demonstrated to influence the translation of
venom proteins from genes transcribed in the venom gland (8),
and their action here may also be partially responsible for gen-
erating the venom variation observed. However, our data sug-
gests that factors acting on the transcription of genomic loci in
the venom gland may also play an important role in influencing
venom composition.
Our analyses also reveal an extremely variable pattern of dif-
ferential transcription, translation, and relative abundance of
toxin paralogs at the gene family level (Fig. 2). Notably, the most
extensive variation in genes encoding toxic proteins was found
in the larger multilocus gene families, with the single loci gene
families approaching a typically 1:1:1 ratio of genomic loci to
transcribed gene to secreted venom protein (Fig. 3B and SI
Appendix, Fig. S15). These results are perhaps unsurprising, but
they further reflect the apparent distinction between pathogeni-
cally important toxin families (e.g., SVMP and SP) and so-called
“ancillary” toxin families (e.g., LAAO and CRISP) described (15).
Here, we demonstrate that this dichotomy appears to extend from
the mode and tempo of gene family evolution noted (15) to the
mechanisms governing toxin transcription and translation.
Venom complexity is further influenced by the effect of post-
translational protein modifications (34, 35). Across the sampled
species, we detected multiple instances of the same toxin being
identified in distinct proteomic fractions (SI Appendix, Tables
S1–S6), signifying the presence of multiple protein products as
the result of proteolysis (SI Appendix, Fig. S16). These obser-
vations likely reflect (i) the proteolytic cleavage of single gene
proteins forming multiple products (e.g., SVMPs; ref. 34) and
(ii) the cleavage of multimeric structures, which can be encoded
by the same gene or different genes from either the same or
distinct toxin families (35). Considerable interspecific variation
in the number of proteolysed toxins was observed, ranging from
three genes in E. p. leakeyi producing six venom protein products,
to 13 forming 36 in B. arietans venom (SI Appendix, Fig. S16A).
Therefore, the extensive interspecies variation observed for gene
transcription and protein translation also extends to the pro-
teolytic cleavage of venom toxins. We also detected extensive
variation across the different toxin families, with the vast ma-
jority detected in the CTLs (43%) and SVMPs (38%). Each
species contained multiple proteolysed toxins from these gene
families in their venom, with the exception of CTLs in C. cerastes
(SI Appendix, Fig. S16B). In contrast, no PLA2 or CRISP toxins
showed evidence of proteolytic cleavage in any venom. Because
evidence of proteolysis appears to be more commonplace in some
toxin families than others, the importance of their respective con-
tribution to the venommixture is likely to be intrinsically associated
to the evolution of each gene family and the representation of such
genes in the genome and venom gland of each species.
The multiple layers of regulation acting on the production of
venom generate surprising diversity in toxin composition, even
between closely related species (Figs. 1 and 3). Variation in ge-
nomic loci, through the duplication or loss of toxin encoding genes
over evolutionary time, is likely to have a major influence on the
generation of venom variation, particularly between taxonomically
distinct groups of snakes, as seen here when comparing Echis with
B. arietans and C. cerastes (e.g., SI Appendix, Figs. S8, S9, and S12).
However, factors influencing the transcription of these genes, and
then their translation, clearly influence the mixture of toxins pres-
ent in these secretions to varying extents (Fig. 3C), although the
action of these mechanisms appears indiscriminate. Nonetheless,
Fig. 4. The effect of venom variation on venom-induced lethality and pathogenicity and the neutralizing efficacy of an antivenom. Comparisons of the in vivo le-
thality (LD50) of each venom tomice (A), scorpions (B), and locusts (C), their in vivo hemorrhagic (D) and in vitro procoagulant activities (E), and their neutralization by
an E. ocellatus-monospecific antivenom, EchiTAbG (F). Asterisks indicate significant differences (P < 0.05) detected between venoms; N.D. indicates not determined;
and N.S. indicates no significant difference. Error bars in A–C and F represent 95% confidence intervals and in D represent SEM. Note that B. arietans and C. cerastes
venoms did not cause procoagulant effects at the highest dose tested (100 μg) and that EchiTAbG was ineffective at preventing lethality caused by E. c. sochureki,
B. arietans, andC. cerastes venoms at the highest dose permittedby the ED50 assay (150 μL). Parts of the data shown inA–C and F are reproduced from refs. 12, 20, and25).
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the result of variation in gene transcription, protein translation, and
proteolytic processing results in secreted venom containing a dras-
tically different toxin composition than predicted by our genome
analyses and the venom gland transcriptome (Fig. 3C), thereby
emphasizing the relative importance of these processes to the
generation of snake venom variation.
Importantly, the generation of venom variation may have serious
medical consequences by causing significant differences in the
toxicity and pathogenicity of different venoms (Fig. 4 and SI Ap-
pendix, Table S7). We previously found no significant difference
between the lethality of the four Echis venoms to laboratory mice
(12), and here we demonstrate that all exhibit comparable lethality
to the venom of C. cerastes (Fig. 4A). However, we find that the
venom of B. arietans is significantly more potent to mice that any of
the Echis venoms (Fig. 4A). Contrastingly, the Echis venoms show
significant interspecific variation in their lethality to (i) scorpions,
where all, apart from E. coloratus, are more potent than the venom
of B. arietans to this prey species (20) (Fig. 4B) and (ii) locusts, to
which E. p. leakeyi venom is significantly more toxic than venoms
from the other Echis species and from B. arietans (25) (Fig. 4C).
Here, we also describe significant variation in specific venom-
induced pathologies that characterize bites by viperid snakes: hem-
orrhage and coagulopathy. The Echis venoms exhibit significant
interspecific variation in their ability to cause hemorrhage in
a murine in vivo model, although the venoms of B. arietans and
C. cerastes are significantly more hemorrhagic than Echis, with
the exception of E. coloratus (Fig. 4D). In contrast, the venoms of
the Echis species are highly procoagulant and capable of clotting
200 μL of human and mouse plasma with less than 0.6 μg of
venom (Fig. 4E). The exception to this observation is the venom
of E. coloratus, which is significantly less procoagulant, although
this disparity is noticeably higher with human plasma than mouse,
further highlighting the apparent unpredictability of taxon-spe-
cific venom activities. Contrastingly, the venoms of B. arietans
and C. cerastes were incapable of inducing clotting, even at 1,000
times the dose required by E. ocellatus venom (Fig. 4E).
The variations in venom-induced lethality and pathology de-
scribed here have medical implications relating to antivenom
therapy. Thus, the antivenom EchiTAbG (manufactured from the
IgG of sheep hyperimmunized with E. ocellatus venom; ref. 4) is
equally effective at neutralizing the lethal effects of venom from
E. ocellatus, E. coloratus, and E. p. leakeyi in vivo (12). These results
emphasize that a certain degree of venom variation does not render
a monospecific antivenom ineffective, so long as there are sufficient
species-common toxin epitopes present to ensure the cross-reactive
efficacy of antivenom antibodies. However, we find that EchiTAbG
antivenom is ineffective at neutralizing venom from E. c. sochureki,
B. arietans, and C. cerastes in a murine preclinical model (Fig. 4F).
In all cases, the maximum dose of antivenom permitted in the
assay failed to prevent venom-induced lethality. The result for
E. c. sochureki is particularly notable because the gross venom
composition of this species appears similar to its congeners
(Fig. 1), thereby highlighting that subtle variation within toxin
families is sufficient to undermine antivenom efficacy. Therefore,
antivenom failure may be the result of a combination of variation
in both genomic and postgenomic processes. Importantly, the
highly variable nature of postgenomic processes acting differen-
tially on gene paralogs highlights why predicting the cross-reactive
efficacy of an antivenom can be exceedingly problematic.
The multiple layers of regulation acting on venom toxins results
in substantial species differences in venom protein composition
and may also be at least partially responsible for differences in
venom toxicity. Ultimately, the combination of genomic and post-
genomic processes causes substantial variation in venom compo-
sition that makes the design of a universal snakebite therapy
extremely problematic. We therefore hope that this research will
stimulate additional investigations to elucidate the specific mech-
anisms controlling venom proteome complexity and, thereby,
improve our understanding of how to better treat an important
neglected tropical disease, snakebite.
Methods
SI Appendix, SI Materials and Methods has additional information relating
to the methodologies described below.
Venom Gland Transcriptomes. Venom gland transcriptomes for B. arietans
(Nigeria) and C. cerastes (Egypt) were constructed using the protocols pre-
viously described for E. ocellatus (Nigeria), E. p. leakeyi (Kenya), E. coloratus
(Egypt), and E. c. sochureki (United Arab Emirates) (26, 27). Briefly, libraries
were constructed by using mRNA extracted from venom glands pooled from
10 individuals of each species by using the CloneMiner method, with ∼1,000
clones sequenced by using Sanger sequencing for each library. Resulting
ESTs were assembled into contigs (putative gene products) and annotated,
and their transcription level was quantified as previously described (26, 27).
Each dataset was then subjected to six frame translations and used as
a reference database to facilitate proteomic identification.
Venom Proteomes. Proteins fromeach crude, lyophilized venom (2mgextracted
from the same individuals used for venomgland transcriptomics)were separated
by reverse-phase HPLC with isolated fractions subjected to N-terminal se-
quencing and molecular mass determination as previously described (28). The
relative abundances (expressed as percentage of the total venom proteins) of
the different protein families were calculated from the relation of the sum of
the areas of the reverse-phase chromatographic peaks (containing proteins
from the same family), to the total area of venom protein peaks in the reverse-
phase chromatogram. The relative contributions of different proteins eluting in
the same chromatographic fraction was estimated by densitometry of Coo-
massie brilliant blue-stained SDS-PAGE gels, as previously outlined (28).
Toxin Evolution. Toxin gene sequences annotated as SVMP, PLA2, CTL,
SP, LAAO, or CRISP in the transcriptomes were extracted and analyzed to
reconstruct their evolutionary history. These gene families were selected based
on the results of the proteomic analyses, which identified the presence of
these toxin types in the venom of the majority of the sampled species. The
remaining toxin family identified and analyzed, the short-coding disintegrins
(DIS), were discarded from phylogenetic analysis due to their apparent con-
vergent evolution from SVMPs (18, 36). For each toxin family, nonredundant
nucleotide sequences from each of the six transcriptomes were aligned with
published gene homologs isolated from the venom systems of other viperid
snakes, using the MUSCLE algorithm (37). Phylogenetic analyses for each
toxin family were performed by incorporating optimized models of sequence
evolution (SI Appendix, Table S8) into MrBayes v3.2 (38). Nucleotide gene
trees were generated in duplicate using four chains for 1 × 107 generations,
sampling every 500th cycle from the chain and using default settings in
regards to priors. Tracer v1.4 (39) was used to estimate effective sample sizes
for all parameters and to verify the point of convergence (burnin), with trees
generated prior to this point discarded. The resulting sequence align-
ments have been submitted to the Dryad Digital Repository, http://
datadryad.org/ (doi:10.5061/dryad.1j292).
Gene and Protein Comparisons. Proteomic matches to transcriptome gene
products were overlaid on to the generated gene trees, alongside calcu-
lations of protein abundance. We applied the following rules to the data: (i)
We conservatively retained the longest nucleotide sequence for each tran-
scriptome contig and discarded all other sequence variants. These sequences
are unlikely to represent distinct genes, but rather are the result of allelic
variation (as 10 specimens were used for library construction). We removed
these sequences to prevent artificial inflation of gene numbers generated
by the reconciliation analyses described below. (ii) Where different contigs
from the same species exhibited monophyly and did not result in distinct
proteome matches, we merged the contigs and discarded nonmatching
sequences because of sequence redundancy. (iii) Sequences from contigs
that were nonmonophyletic with other contigs from the same species and
had no proteomic match were retained and annotated with “no proteomic
hit”, indicative of nontranslation of the transcript. (iv) Posttranslational
modifications (i.e., proteolytic cleavage) were assigned where multiple
proteomic matches to the same transcriptome cluster were found in dis-
tinct nonoverlapping proteomic fractions.
Gene/Species Tree Reconciliation.We reconciled the resulting gene trees with
the species tree presented in Fig. 1 by using NOTUNG.v2.6 (31). Each Echis/
Bitis/Cerastes toxin clade was analyzed separately by using the reconciliation
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option, which produces a reconciled tree displaying the timing of gene
duplication and loss events, and the predicted number of gene loci. Because
NOTUNG permits the reconciliation of genes trees to nonbinary species trees
(31), we used this option when clade support in the gene tree exhibited
a Bayesian posterior probability of <0.95. This approach allowed nodes that
were not robustly supported in the gene tree to be reconciled with a poly-
tomous species tree. We used this conservative approach to mitigate the
generation of spurious gene duplication events that would otherwise be
generated as artifacts of uncertainty in the gene tree.
Functional Studies. The same venom samples used for proteomic analyses were
used for functional assessments. All animal experimentationwas conducted using
standard protocols approved by the Liverpool School of TropicalMedicineAnimal
Welfare and Ethical ReviewBoard and theUKHomeOffice (license no. 40/3216, 40/
3151,40/3718).Murine invivo lethality studies (12)wereconductedtocalculatethe
lethal dose 50 (LD50; the amount of venom that kills 50% of injected mice) for B.
arietans and C. cerastes venom. We used the same murine model to test the effi-
cacy of the E. ocellatus monospecific antivenom, EchiTAbG, at neutralizing five
times the venomLD50 for B. arietans and C. cerastes in the effective dose 50 (ED50)
assay (12). Both sets of experiments were undertaken as previously described using
venom from the four Echis species (12), with comparisons undertaken using the
95% confidence limits generated by probit analysis (40). LD50 values for venom
lethality to scorpions and locusts were reproduced from our earlier work (20, 25).
Modified minimum hemorrhagic dose (MHD) experiments (41) were undertaken
to compare the hemorrhagic activity of each venom. Ten-microgram doses of
venomwere injected intradermally into the dorsal skin of groups of anesthetized
miceandtheskin lesionsizemeasuredafter24h.Themeandiameterofeachlesion
was compared using paired two-tailed t tests with a P value threshold of 0.05. The
procoagulant activity of each venom was determined using the minimum co-
agulantdose (MCD-P) assay (41). Varyingdosesof venomwere incubatedwith200
μLofhumanormouseplasma (Sigma)at 37°C, and theclotting timewas recorded.
The60-s clotting timewas calculatedbyplotting clotting timeagainst venomdose,
and statistical comparison of different venoms were undertaken using regression
analysis of the resulting lines with a P value threshold of 0.05.
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